M
MEDU LABORATORIES
Vendor Ledger/EHZ Peptides
E

EHZ Peptides

CAverage 35 products · 81 certificates

Products examined

ProductRating Samples Avg MinMaxLatest
Retatrutide C 25 7.1 4.6 10.0 20 Jun 2025
Tirzepatide C 14 6.3 4.1 9.9 25 Jul 2025
4-Anilinopiperidine CAS 99918-43-1 C 3 6.7 6.0 7.5 20 May 2026
5-amino-1MQ C 3 6.3 5.8 7.3 24 May 2026
Aromasin (Exemestane) C 3 6.1 4.7 7.9 23 May 2026
Boldenone Cypionate C 2 6.7 6.3 7.0 21 May 2026
BPC157 10mg + TB500 10mg Blend C 3 6.0 4.8 7.7 21 May 2026
Cagrilintide 5mg + Semaglutide 5mg Blend X 1 6.6 6.6 6.6 3 Jun 2025
Chonluten X 1 6.3 6.3 6.3 27 Feb 2025
CJC-1295 With DAC X 1 5.5 5.5 5.5 11 Jun 2025
Cortagen C 3 6.5 4.5 8.8 19 Jan 2026
DHB (1-Test Cyp) C 2 6.5 5.9 7.1 26 Jan 2026
Dianabol Raw C 3 7.1 6.4 7.9 24 May 2026
DSIP C 2 8.9 8.5 9.4 17 May 2026
EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 C 3 6.6 6.5 6.8 25 May 2026
Epithalon C 3 6.5 6.1 6.9 21 May 2026
GHRP-6 Acetate X 1 8.1 8.1 8.1 3 Jul 2025
Hyaluronic acid X 1 8.3 8.3 8.3 27 Feb 2025
Ivermectin C 3 6.6 6.2 7.0 26 Jan 2026
MOTS-C C 2 7.0 5.7 8.3 24 May 2026
MT-1 C 3 6.4 5.0 7.7 25 May 2026
N-Acetyl Epitalon Amidate X 1 7.5 7.5 7.5 2 Apr 2025
Orforglipron X 1 7.7 7.7 7.7 2 Jul 2025
P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 C 3 6.5 4.7 9.5 20 May 2026
PE 22-28 C 3 7.5 5.9 9.5 17 May 2026
Proviron (Mesterolone) Raw X 1 9.0 9.0 9.0 17 Dec 2024
RAD140 C 2 8.1 7.8 8.3 23 May 2026
Selank 10mg + Semax 10mg Blend C 3 5.8 5.1 6.3 24 May 2026
Semax C 2 7.0 6.0 8.0 21 May 2026
SR9009 C 3 6.3 6.0 6.7 20 May 2026
Super Shred C 3 8.0 6.8 9.9 21 May 2026
Test Enanthate C 3 4.9 4.0 6.6 24 May 2026
Thymosin Alpha-1 C 3 7.9 7.0 9.4 25 May 2026
Tirzepatide Oral C 2 5.1 4.8 5.4 21 May 2026
YK-11 Raw X 1 9.0 9.0 9.0 2 Jul 2025

The certificates

DateProductScoreDeclared MeasuredDeviationPurityLaboratory
25 May 2026 MT-1 5.3 50mg 52.2mg +4.5% 95.44% Lab D
24 May 2026 DHB (1-Test Cyp) 9.4 250mg/ml 234.6mg/ml -6.2% 96.87% Lab F
24 May 2026 EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 6.8 500g 525.5g +5.1% 98.34% Lab E
24 May 2026 MT-1 5.6 20mg 24.7mg +23.5% 95.90% Lab G
24 May 2026 PE 22-28 7.1 30mg 32.1mg +7.1% 99.58% Lab D
24 May 2026 Test Enanthate 5.6 250mg/ml 294.9mg/ml +18.0% 97.14% Lab E
24 May 2026 Retatrutide 6.5 15mg 13.8mg -8.0% 99.70% Lab G
24 May 2026 Aromasin (Exemestane) 7.1 100mg 123.2mg +23.2% 96.69% Lab C
24 May 2026 Cortagen 6.0 5mg 4.5mg -9.5% 96.75% Lab E
24 May 2026 Dianabol Raw 5.3 5g 6.2g +24.3% 96.79% Lab F
24 May 2026 P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 5.6 10g 11.5g +14.7% 99.12% Lab G
24 May 2026 P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 6.6 100g 88.7g -11.3% 99.30% Lab A
24 May 2026 5-amino-1MQ 5.7 15mg 18.3mg +22.2% 95.65% Lab A
24 May 2026 Cortagen 6.4 50mg 48.7mg -2.7% 98.27% Lab B
24 May 2026 YK-11 Raw 9.4 500g 428.9g -14.2% 96.10% Lab C
23 May 2026 EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 6.7 1g 1.1g +12.7% 96.61% Lab C
23 May 2026 Hyaluronic acid 9.0 10mg 11.7mg +16.6% 99.33% Lab D
23 May 2026 N-Acetyl Epitalon Amidate 7.7 5mg 4.6mg -7.5% 95.38% Lab F
23 May 2026 Semax 5.6 10mg 9.3mg -6.8% 98.21% Lab D
21 May 2026 Tirzepatide 7.8 30mg 31.3mg +4.3% 99.83% Lab E
21 May 2026 4-Anilinopiperidine CAS 99918-43-1 7.4 100g 109.6g +9.6% 96.35% Lab B
21 May 2026 Thymosin Alpha-1 10.0 10mg 10.8mg +7.7% 97.80% Lab D
21 May 2026 Aromasin (Exemestane) 4.0 50mg 51.4mg +2.8% 96.52% Lab F
21 May 2026 SR9009 5.7 25mg 24.3mg -3.0% 98.66% Lab E
21 May 2026 Test Enanthate 8.1 300mg/ml 264.9mg/ml -11.7% 96.78% Lab A
20 May 2026 Retatrutide 9.8 50mg 49.7mg -0.6% 99.80% Lab G
20 May 2026 Boldenone Cypionate 7.3 200mg/ml 214.0mg/ml +7.0% 99.85% Lab E
20 May 2026 Epithalon 5.8 20mg 18.7mg -6.4% 97.06% Lab E
20 May 2026 GHRP-6 Acetate 7.9 2mg 2.0mg +1.7% 96.99% Lab A
19 May 2026 Tirzepatide 6.5 60mg 54.5mg -9.2% 99.80% Lab G
19 May 2026 Retatrutide 6.3 30mg 32.9mg +9.7% 99.80% Lab G
19 May 2026 5-amino-1MQ 7.4 5mg 4.3mg -14.2% 96.95% Lab D
19 May 2026 Ivermectin 7.2 10mg 9.9mg -0.8% 95.54% Lab F
19 May 2026 Ivermectin 7.2 25mg 28.4mg +13.4% 99.85% Lab G
19 May 2026 Proviron (Mesterolone) Raw 8.9 5g 5.1g +1.3% 97.57% Lab C
19 May 2026 Retatrutide 7.0 10mg 10.8mg +8.0% 99.90% Lab E
17 May 2026 Boldenone Cypionate 5.4 200mg/ml 190.0mg/ml -5.0% 96.52% Lab E
29 Jan 2026 BPC157 10mg + TB500 10mg Blend 7.5 2mg 1.9mg -6.2% 96.66% Lab C
29 Jan 2026 Thymosin Alpha-1 7.3 10mg 11.9mg +19.4% 98.89% Lab C
29 Jan 2026 Thymosin Alpha-1 8.8 10mg 9.9mg -1.2% 98.53% Lab C
26 Jan 2026 Tirzepatide 6.1 20mg 22.1mg +10.5% 99.80% Lab G
26 Jan 2026 4-Anilinopiperidine CAS 99918-43-1 8.5 500g 559.1g +11.8% 95.78% Lab F
26 Jan 2026 Aromasin (Exemestane) 4.9 50mg 54.0mg +8.0% 95.51% Lab A
19 Jan 2026 MOTS-C 5.8 15mg 13.0mg -13.1% 95.71% Lab D
9 Jan 2026 Epithalon 7.3 20mg 18.0mg -10.0% 99.48% Lab G
9 Jan 2026 Epithalon 5.8 2mg 2.2mg +10.2% 95.18% Lab D
7 Jan 2026 Dianabol Raw 6.8 1g 1.1g +11.9% 98.18% Lab F
7 Jan 2026 DSIP 8.8 15mg 13.7mg -8.7% 98.50% Lab D
7 Jan 2026 P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 5.6 500g 495.1g -1.0% 97.15% Lab G
7 Jan 2026 SR9009 7.3 100mg 108.8mg +8.8% 99.61% Lab G
6 Jan 2026 CJC-1295 With DAC 4.7 30mg 33.7mg +12.2% 99.39% Lab D
6 Jan 2026 MOTS-C 8.5 5mg 5.6mg +12.4% 96.54% Lab B
6 Jan 2026 Selank 10mg + Semax 10mg Blend 5.7 20mg 20.3mg +1.5% 98.74% Lab C
6 Jan 2026 Test Enanthate 4.1 100mg/ml 119.2mg/ml +19.2% 96.23% Lab C
29 Dec 2025 4-Anilinopiperidine CAS 99918-43-1 6.6 10g 9.1g -9.2% 99.99% Lab B
29 Dec 2025 Cagrilintide 5mg + Semaglutide 5mg Blend 5.8 5mg 4.4mg -11.2% 95.22% Lab C
29 Dec 2025 Semax 7.4 50mg 49.5mg -0.9% 95.33% Lab D
29 Dec 2025 Super Shred 7.3 300mg/ml 311.8mg/ml +3.9% 99.48% Lab D
29 Dec 2025 Tirzepatide Oral 7.7 100mg 85.2mg -14.8% 98.23% Lab E
12 Dec 2025 DSIP 10.0 20mg 23.9mg +19.4% 96.05% Lab B
12 Dec 2025 Super Shred 7.8 300mg/ml 294.1mg/ml -2.0% 95.02% Lab B
5 Dec 2025 BPC157 10mg + TB500 10mg Blend 8.6 15mg 18.3mg +21.9% 97.28% Lab G
5 Dec 2025 Cortagen 6.9 50mg 49.2mg -1.5% 97.96% Lab A
23 Nov 2025 5-amino-1MQ 5.7 30mg 32.8mg +9.4% 98.30% Lab B
23 Nov 2025 DHB (1-Test Cyp) 6.8 250mg/ml 307.7mg/ml +23.1% 96.46% Lab G
23 Nov 2025 EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 5.7 500g 569.7g +13.9% 99.31% Lab A
23 Nov 2025 Orforglipron 7.4 20mg 17.8mg -11.1% 98.27% Lab C
23 Nov 2025 RAD140 8.1 50mg 52.6mg +5.2% 97.62% Lab B
23 Nov 2025 Super Shred 7.5 250mg/ml 218.3mg/ml -12.7% 99.31% Lab A
17 Nov 2025 BPC157 10mg + TB500 10mg Blend 6.9 5mg 5.7mg +14.6% 95.49% Lab E
17 Nov 2025 PE 22-28 6.6 20mg 19.4mg -3.1% 97.37% Lab E
14 Nov 2025 Chonluten 5.3 5mg 6.0mg +19.8% 96.47% Lab B
14 Nov 2025 PE 22-28 6.9 30mg 35.2mg +17.2% 97.89% Lab G
14 Nov 2025 Selank 10mg + Semax 10mg Blend 6.0 2mg 2.4mg +20.2% 98.88% Lab B
5 Nov 2025 Ivermectin 5.9 20mg 19.6mg -2.1% 99.72% Lab E
5 Nov 2025 SR9009 7.8 25mg 24.1mg -3.7% 95.39% Lab F
17 Oct 2025 Selank 10mg + Semax 10mg Blend 4.0 2mg 2.5mg +24.5% 99.11% Lab F
17 Oct 2025 Tirzepatide Oral 4.6 20mg 18.4mg -8.2% 95.01% Lab A
9 Oct 2025 MT-1 7.4 10mg 9.6mg -4.4% 96.78% Lab G
9 Oct 2025 RAD140 4.7 20mg 21.6mg +8.1% 96.10% Lab B
3 Oct 2025 Dianabol Raw 9.3 10g 12.1g +21.4% 97.62% Lab E